Medicamen Organics Limited is engaged in developing, manufacturing, and distributing a broad range of pharmaceutical dosages including generic dosages in the form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. They market their product to private pharma companies in domestic as well as international markets through third-party distributors or on a loan license basis. Further, their Company is also strategically focusing on establishing a direct presence in the international market for instance in fiscal 2023, they have directly exported their product to Burundi. They have a track record of operating a B2B model which covers the contract manufacturing model. Their products are marketed across India as well as African, CIS, and South East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan, and Kenya by their third-party distributor.
They have 2 WHO GMP-approved manufacturing facilities located at 60 and 61, Sector 6A, I.I.E. SIDCUL, Ranipur, Haridwar 249403, Uttarakhand spread across 21,536 sq. Ft. Their manufacturing facilities are capable of producing pharmaceutical formulations and products and have a fully equipped quality control department with experienced and qualified staff to facilitate a smooth manufacturing process. They have an in-house testing laboratory and the necessary infrastructure to test their raw materials and finished products to match the quality standards. They are an ISO 9001:2015 certified company. their core strength lies in product development and documentation, which gives them an inherent strength in the market as they are regularly engaged in research and development and launching new products. This gives them an ever-evolving product list as well as better pricing in the market. Their product portfolio consists of 84 products and comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Non-steroidal anti-inflammatory drug (NSAIDS).
Their Company is consistent in supplying quality products around the year. Their products comply with requisite safety standards. They are a quality-conscious company. They are constantly striving to expand their line of products and they are always looking for complementary products that will add to their range of products.
Objects of the Issue:
- Funding of expenses proposed to be incurred towards Product registration in the international markets
- Plant updation and increase in production capacity
- Funding working capital requirements of our Company
- General Corporate Purposes
Medicamen Organics IPO Review
- To be updated soon
Medicamen Organics IPO Date & Price Band Details
| IPO Open: | June 21, 2024 |
| IPO Close: | June 25, 2024 |
| IPO Size: | Approx ₹10.54 Crores, 3,100,000 Equity Shares |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹32 to ₹34 Per Equity Share |
| IPO Listing on: | NSE SME |
| Retail Quota: | 35% of the net offer |
| QIB Quota: | 50% of the net offer |
| NII Quota: | 15% of the net offer |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors in IPO: | Click Here |
Medicamen Organics IPO Market Lot
The Medicamen Organics IPO minimum market lot is 4000 shares with a ₹136,000 application amount.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 4000 | ₹136,000 |
| Retail Maximum | 1 | 4000 | ₹136,000 |
| S-HNI Minimum | 2 | 8000 | ₹272,000 |
Medicamen Organics IPO Dates
The Medicamen Organics IPO date is June 21 and the IPO close date is June 25. The IPO allotment date is June 26 and the IPO might list on June 28.
| IPO Open Date: | June 21, 2024 |
| IPO Close Date: | June 25, 2024 |
| Basis of Allotment: | June 26, 2024 |
| Refunds: | June 27, 2024 |
| Credit to Demat Account: | June 27, 2024 |
| IPO Listing Date: | June 28, 2024 |
You can check IPO subscription status and IPO allotment status on their respective pages.
Medicamen Organics IPO Form
How to apply Medicamen Organics IPO? You can apply Medicamen Organics IPO via ASBA available in your bank account. Just go to the online bank login and apply via your bank account by selecting the Medicamen Organics IPO in the Invest section. The other option you can apply Medicamen Organics IPO via IPO forms download via the BSE website. Check out the Medicamen Organics forms – click BSE IPO Forms download, fill and submit in your bank or with your broker.
Medicamen Organics Company Financial Report
| ₹ in Crores | |||
| Year | Revenue | Expense | PAT |
| 2021 | ₹25.06 | ₹24.57 | ₹0.30 |
| 2022 | ₹21.19 | ₹20.93 | ₹0.09 |
| 2023 | ₹22.96 | ₹21.60 | ₹0.96 |
| September 2023 | ₹11.33 | ₹9.57 | ₹1.29 |
Medicamen Organics IPO Valuation – FY2023
Check Medicamen Organics IPO valuations detail like Earning Per Share (EPS), Price/Earning P/E Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| Earning Per Share (EPS): | ₹1.60 per Equity Share |
| Price/Earning P/E Ratio: | [.] |
| Return on Net Worth (RoNW): | 11.25% |
| Net Asset Value (NAV): | ₹14.20 per Equity Share |
Peer Group
- Brooks Laboratories Ltd
- Cian Healthcare Ltd
- Zenotech Laboratories Ltd
Company Promoters
- Mr. Bal Kishan Gupta
Medicamen Organics IPO Registrar
Kfin Technologies Limited
Phone: 04067162222, 04079611000
Email: [email protected]
Website: https://kosmic.kfintech.com/ipostatus/
Medicamen Organics IPO Allotment Status
Check Medicamen Organics IPO allotment status on Kfintech website URL. Click Here
Medicamen Organics IPO Lead Managers aka Merchant Bankers
- GYR Capital Advisors Private Limited
Company Address
Medicamen Organics Limited
10 Community Centre,
No 2 Ashok Vihar Phase II,
New Delhi, Delhi, 110052
Phone: +91-9818222845
Email: [email protected]
Website: http://www.medicamenorganics.com/
